by editor | Oct 9, 2014 | Blog, Medical Stocks
GeoVax Chairman Interviewed on the Fox Business Network and on Glenn Beck’s TheBlaze TV Watch David Dodd Discuss GeoVax’s Recent Initiation of an Ebola Vaccine Program and the Rising Threat of the Global Epidemic David Dodd, Chairman of GeoVax Labs, Inc....
by editor | Jul 16, 2014 | Blog, Breaking News, Featured, Medical Stocks, Update
GeoVax Awarded Small Business Innovative Research (SBIR) Grant from National Institutes of Health GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing vaccines to prevent and treat HIV/AIDS, announced today it has received a Notice of Award from the...
by editor | Jan 23, 2013 | Asides, Blog
GeoVax Labs, Inc. (OTCQB: GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to prevent and treat HIV/AIDS, unveiled its new website January 23rd. The site, www.geovax.com, incorporates numerous features to make browsing a more fruitful experience for...
by editor | Sep 2, 2011 | Latest Spotlights, Medical Stocks
Aggregate Total Award of $20.4 Million for Clinical Development of HIV/AIDS Vaccine Dallas, Texas (September 2, 2011) – StockGuru Shines its Spotlight on GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to...
by editor | Jun 24, 2011 | Latest Spotlights, StockGuru, StockGuru Blog
Dallas, Texas. June 24, 2011. StockGuru’s Bio-tech focus is on GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines. The therapeutic trial announced yesterday is the first trial to test...
